Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03205176
Title Phase I Study of AZD5153 in Patients With Relapsed or Refractory Solid Tumors and Lymphomas
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Research Site Sarasota Florida 34232 United States Details
Research Site Oklahoma City Oklahoma 73104 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Toronto CA M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field